SCHEMBL24130498

SCHEMBL24130498

CC(C)n1c(=O)n(C)c2ncc(NN=C(C#N)C#N)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ TDP1 Q9NUW8 5/20 0.38
▸ NPSR1 Q6W5P4 3/20 0.38
▸ HTT P42858 4/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ MEN1 O00255 8/20 0.33
▸ KMT2A Q03164 8/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CISD1 Q9NZ45 1/20 0.33
▸ PDE3B Q13370 2/20 0.33
▸ PDE3A Q14432 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24130532 0.92 MAPT (0.37) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL24130531 0.92 MAPT (0.39) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL24130149 0.90 MAPT (0.37) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL24130525 0.89 HTT (0.46) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL24130530 0.87 MAPT (0.35) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL26280634 0.85 MAPT (0.41) MAPTALDH1A1TDP1HTTHSD17B10
SCHEMBL24130516 0.85 ALDH1A1 (0.34) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL24130499 0.84 ALDH1A1 (0.38) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL24130132 0.82 MAPT (0.35) MAPTALDH1A1TDP1NPSR1HTT
SCHEMBL24130675 0.81 HPD (0.41) MAPTALDH1A1TDP1NPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed
WO-2021256899-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF 한국과학기술연구원 2021-12-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT MAPT 3518/4885ALDH1A1 1343/4885TDP1 2868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback